Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.82	83.01	98.43	156.15	59.77	168.2
Short-Term Investments	192.66	315.97	368.63	311.14	230.69	42.01
Cash & Short-Term Investments	265.48	398.98	467.07	467.29	290.47	210.21
Cash Growth	-59.93%	-14.58%	-0.05%	60.88%	38.18%	113.13%
Other Current Assets	10.43	15.69	13.12	7.18	6.1	2.07
Total Current Assets	275.91	414.67	480.19	474.47	296.56	212.28
Net Property, Plant & Equipment	1.75	2.35	3.53	5.3	0.08	0.13
Long-Term Investments	242.3	204.44	-	80.88	140.4	-
Other Long-Term Assets	0.37	0.37	0.46	0.46	0.15	2.3
Total Assets	520.33	621.82	484.18	561.12	437.19	214.71
Accounts Payable	2.46	1.68	2.49	2.66	3.17	9.68
Accrued Expenses	24.2	27.66	24.2	14.14	8.58	4.64
Current Portion of Leases	1.39	1.3	1.44	1.42	-	-
Other Current Liabilities	-	-	-	4.28	-	-
Total Current Liabilities	28.06	30.65	28.14	22.5	11.75	14.32
Long-Term Leases	0.13	0.85	2.15	3.59	-	-
Other Long-Term Liabilities	-	-	-	-	0.07	0.07
Total Long-Term Liabilities	0.13	0.85	2.15	3.59	0.07	0.07
Total Liabilities	28.18	31.5	30.29	26.09	11.81	14.39
Common Stock	0.01	0.01	0	0.01	0	0
Additional Paid-in Capital	978.33	958.7	654.69	585.32	584.71	292.35
Accumulated Other Comprehensive Income	0.61	-0.13	-0.13	-2.6	-0.84	-0
Retained Earnings	-486.8	-368.24	-200.86	-47.7	-158.91	-93.34
Total Common Shareholders' Equity	492.15	590.33	453.7	535.03	424.97	199.01
Minority Interest	-	-	0.19	-	0.4	1.3
Shareholders' Equity	492.15	590.33	453.9	535.03	425.37	200.31
Total Liabilities & Equity	520.33	621.82	484.18	561.12	437.19	214.71
Total Debt	1.52	2.15	3.59	5.01	0	0
Net Cash (Debt)	263.96	396.83	463.48	462.28	290.47	210.21
Net Cash Growth	-33.48%	-14.38%	0.26%	59.15%	38.18%	113.13%
Net Cash Per Share	4.64	7.62	11.11	9.91	6.74	10.57
Book Value	492.15	590.33	453.7	535.03	424.97	199.01
Book Value Per Share	8.65	11.34	10.88	11.47	9.87	10.01
Tangible Book Value	492.15	590.33	453.7	535.03	424.97	199.01
Tangible Book Value Per Share	8.65	11.34	10.88	11.47	9.87	10.01

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q